Tiziana A.L. Brevini

Dr. Tiziana A.L. Brevini

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 April 2006 in Fertility and Sterility
Verified
Journal Article
Closed access
Fulvio GandolfiFulvio Gandolfi
Fulvio Gandolfi
APAlessio Paffoni
Alessio Paffoni
EBElide Papasso Brambilla
Elide Papasso Brambilla
SBSilvia Bonetti
Silvia Bonetti
TBTiziana A.L. Brevini
Tiziana A.L. Brevini
GRGuido Ragni
Guido Ragni

1 November 2007 in Reproduction
Verified
Journal Article
Closed access
FCFabiana Cillo
Fabiana Cillo
TBTiziana A.L. Brevini
Tiziana A.L. Brevini
SAStefania Antonini
Stefania Antonini
APAlessio Paffoni
Alessio Paffoni
GRGuido Ragni
Guido Ragni
Fulvio GandolfiFulvio Gandolfi
Fulvio Gandolfi
At present, oocyte selection is mainly based upon morphological criteria but it is generally acknowledged that its reliability requires further improvement. The aim of this study was to determine whether transcript levels in cumulus cells can provide a useful marker of oocyte developmental competence in vitro. A retrospective study was performed on cumulus cells isolated from 90 oocytes retrieved from 45 patients. Upon fertilization, 35 oocytes originated good-quality embryos and 36 developed into poor-quality embryos, whereas 19 failed to be fertilized. Semi-quantitative measurement of hyaluronic acid synthase 2 (HAS2), gremlin1 (GREM1), and pentraxin 3 (PTX3) mRNAs was performed and data for all genes were obtained from all the samples. Cumulus cells isolated from oocytes that originated high-quality embryos on day 3 of culture had HAS2 and GREM1 transcript levels higher than those detected in cells from oocytes that did not fertilize or developed into poor-quality embryos. No differences were observed in PTX3 levels. Results indicate that the measurement of HAS2 and GREM1 levels in cumulus cells would reliably complement the morphological evaluation providing a useful tool for selecting oocytes with greater chances to be fertilized and develop in vitro.

1 May 2005 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
TBTiziana A.L. Brevini
Tiziana A.L. Brevini
RVRita Vassena
Rita Vassena
CFChiara Francisci
Chiara Francisci
Fulvio GandolfiFulvio Gandolfi
Fulvio Gandolfi
The purpose of this work was to determine the mechanisms regulating the acquisition of cytoplasmic maturation and embryonic developmental competence

5 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
RPRolando Pasquariello
Rolando Pasquariello
NVNicole Verdile
Nicole Verdile
TBTiziana A.L. Brevini
Tiziana A.L. Brevini
Fulvio GandolfiFulvio Gandolfi
Fulvio Gandolfi
CBCristiano Boiti
Cristiano Boiti
Margherita MaranesiMargherita Maranesi
Margherita Maranesi
Resveratrol is one of the most investigated natural polyphenolic compounds and is contained in more than 70 types of plants and in red wine. The widespread interest in this polyphenol derives from its antioxidant, anti-inflammatory and anti-aging properties. Several studies have established that resveratrol regulates animal reproduction. However, the mechanisms of action and the potential therapeutic effects are still unclear. This review aims to clarify the role of resveratrol in male and female reproductive functions, with a focus on animals of veterinary interest. In females, resveratrol has been considered as a phytoestrogen due to its capacity to modulate ovarian function and steroidogenesis via sirtuins, SIRT1 in particular. Resveratrol has also been used to enhance aged oocyte quality and as a gametes cryo-protectant with mainly antioxidant and anti-apoptotic effects. In males, resveratrol enhances testes function and spermatogenesis through activation of the AMPK pathway. Furthermore, resveratrol has been supplemented to semen extenders, improving the preservation of sperm quality. In conclusion, resveratrol has potentially beneficial effects for ameliorating ovarian and testes function.

21 May 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GPGeorgia Pennarossa
Georgia Pennarossa
SMSara Maffei
Sara Maffei
MCMarino Campagnol
Marino Campagnol
LTLetizia Tarantini
Letizia Tarantini
Fulvio GandolfiFulvio Gandolfi
Fulvio Gandolfi
TBTiziana A.L. Brevini
Tiziana A.L. Brevini
The differentiated state of mature cells of adult organisms is achieved and maintained through the epigenetic regulation of gene expression, which consists of several mechanisms including DNA methylation. The advent of induced pluripotent stem cell technology enabled the conversion of adult cells into any other cell type passing through a stable pluripotency state. However, indefinite pluripotency is unphysiological, inherently labile, and makes cells prone to culture-induced alterations. The direct conversion of one cell type to another without an intermediate pluripotent stage is also possible but, at present, requires the viral transfection of appropriate transcription factors, limiting its therapeutic potential. The aim of this study was to investigate whether it is possible to achieve the direct conversion of an adult cell by exposing it to a demethylating agent immediately followed by differentiating culture conditions. Adult human skin fibroblasts were exposed for 18 h to the DNA methyltransferase inhibitor 5-azacytidine, followed by a three-step protocol for the induction of endocrine pancreatic differentiation that lasted 36 d. At the end of this treatment, 35 ± 8.9% fibroblasts became pancreatic converted cells that acquired an epithelial morphology, produced insulin, and then released the hormone in response to a physiological glucose challenge in vitro. Furthermore, pancreatic converted cells were able to protect recipient mice against streptozotocin-induced diabetes, restoring a physiological response to glucose tolerance tests. This work shows that it is possible to convert adult fibroblasts into insulin-secreting cells, avoiding both a stable pluripotent stage and any transgenic modification.